National Health Investors Stock Buy Hold or Sell Recommendation
| NHI Stock | USD 75.10 1.73 2.36% |
Considering the 90-day investment horizon and your above-average risk tolerance, our recommendation regarding National Health Investors is 'Strong Hold'. The recommendation algorithm takes into account all of National Health's available fundamental, technical, and predictive indicators you will find on this site.
Check out National Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. In addition, we conduct extensive research on individual companies such as National and provide practical buy, sell, or hold advice based on investors' investing horizon and their risk tolerance towards National Health Investors. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate.
National |
Execute National Health Buy or Sell Advice
The National recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on National Health Investors. Macroaxis does not own or have any residual interests in National Health Investors or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute National Health's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Strong Hold
Market Performance | Modest | Details | |
Volatility | Very steady | Details | |
Hype Condition | Low key | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Investor Sentiment | Interested | Details | |
Analyst Consensus | Buy | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Not Rated | Details | |
Reporting Quality (M-Score) | Possible Manipulator | Details |
National Health Trading Alerts and Improvement Suggestions
| About 70.0% of the company shares are owned by institutional investors | |
| On 29th of January 2025 National Health paid $ 0.9 per share dividend to its current shareholders | |
| Latest headline from finance.yahoo.com: INN or NHI Which Is the Better Value Stock Right Now |
National Health Returns Distribution Density
The distribution of National Health's historical returns is an attempt to chart the uncertainty of National Health's future price movements. The chart of the probability distribution of National Health daily returns describes the distribution of returns around its average expected value. We use National Health Investors price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of National Health returns is essential to provide solid investment advice for National Health.
| Mean Return | 0.02 | Value At Risk | -2.79 | Potential Upside | 2.33 | Standard Deviation | 1.48 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of National Health historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
National Stock Institutional Investors
| Shares | Norges Bank | 2024-12-31 | 610.7 K | Bank Of New York Mellon Corp | 2024-12-31 | 557.4 K | Marshall Wace Asset Management Ltd | 2024-12-31 | 551.6 K | Millennium Management Llc | 2024-12-31 | 488.4 K | Prudential Financial Inc | 2024-12-31 | 476.4 K | Land & Buildings Investment Mgmt, Llc | 2024-12-31 | 467.1 K | Sumitomo Mitsui Trust Group Inc | 2024-12-31 | 463.4 K | Centersquare Investment Management Llc | 2024-12-31 | 394.4 K | Mirae Asset Global Etfs Holdings Ltd. | 2024-12-31 | 390.1 K | Vanguard Group Inc | 2024-12-31 | 6.4 M | Blackrock Inc | 2024-12-31 | 4.6 M |
National Health Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change In Cash | 30.7M | (6.9M) | (18.0M) | 3.1M | 1.9M | 955.6K | |
| Free Cash Flow | 232.1M | 210.8M | 185.3M | 180.7M | 207.8M | 218.2M | |
| Depreciation | 83.2M | 80.8M | 70.9M | 70.0M | 71.4M | 75.0M | |
| Other Non Cash Items | (18.4M) | 39.2M | 43.0M | (27.8M) | (1.9M) | (2.0M) | |
| Capital Expenditures | 102.9M | 64K | 6.4M | 3.7M | 4.1M | 3.9M | |
| Net Income | 185.3M | 112.0M | 65.5M | 134.4M | 136.6M | 89.4M | |
| End Period Cash Flow | 46.3M | 39.5M | 21.5M | 24.6M | 26.5M | 30.5M | |
| Dividends Paid | 194.6M | 182.9M | 161.8M | 156.2M | 156.5M | 97.8M | |
| Investments | (12.6M) | 1.2M | 40.0M | (11.6M) | (192.3M) | (182.7M) | |
| Net Borrowings | 192.3M | 51.6M | (260.6M) | (98M) | (88.2M) | (83.8M) | |
| Change To Netincome | (21.0M) | (35.5M) | 13.2M | (7.8M) | (7.0M) | (7.4M) |
National Health Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to National Health or Diversified REITs sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that National Health's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a National stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.06 | |
β | Beta against Dow Jones | 0.45 | |
σ | Overall volatility | 1.48 | |
Ir | Information ratio | 0.08 |
National Health Volatility Alert
National Health Investors has relatively low volatility with skewness of -0.46 and kurtosis of 0.02. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure National Health's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact National Health's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.National Health Fundamentals Vs Peers
Comparing National Health's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze National Health's direct or indirect competition across all of the common fundamentals between National Health and the related equities. This way, we can detect undervalued stocks with similar characteristics as National Health or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of National Health's fundamental indicators could also be used in its relative valuation, which is a method of valuing National Health by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare National Health to competition |
| Fundamentals | National Health | Peer Average |
| Return On Equity | 0.1 | -0.31 |
| Return On Asset | 0.0463 | -0.14 |
| Profit Margin | 0.41 % | (1.27) % |
| Operating Margin | 0.63 % | (5.51) % |
| Current Valuation | 4.47 B | 16.62 B |
| Shares Outstanding | 45.69 M | 571.82 M |
| Shares Owned By Insiders | 4.71 % | 10.09 % |
| Shares Owned By Institutions | 70.42 % | 39.21 % |
| Number Of Shares Shorted | 2.07 M | 4.71 M |
| Price To Earning | 13.23 X | 28.72 X |
| Price To Book | 2.45 X | 9.51 X |
| Price To Sales | 10.22 X | 11.42 X |
| Revenue | 257.05 M | 9.43 B |
| Gross Profit | 324.42 M | 27.38 B |
| EBITDA | 264.16 M | 3.9 B |
| Net Income | 136.64 M | 570.98 M |
| Cash And Equivalents | 19.29 M | 2.7 B |
| Cash Per Share | 0.97 X | 5.01 X |
| Total Debt | 1.15 B | 5.32 B |
| Debt To Equity | 0.78 % | 48.70 % |
| Current Ratio | 2.78 X | 2.16 X |
| Book Value Per Share | 33.73 X | 1.93 K |
| Cash Flow From Operations | 207.77 M | 971.22 M |
| Short Ratio | 10.24 X | 4.00 X |
| Earnings Per Share | 3.13 X | 3.12 X |
| Price To Earnings To Growth | 1.99 X | 4.89 X |
| Target Price | 80.86 | |
| Number Of Employees | 30 | 18.84 K |
| Beta | 1.12 | -0.15 |
| Market Capitalization | 3.43 B | 19.03 B |
| Total Asset | 2.61 B | 29.47 B |
| Retained Earnings | 2.6 B | 9.33 B |
| Working Capital | (17.44 M) | 1.48 B |
Note: Acquisition by D Mendelsohn of 25000 shares of National Health at 73.34 subject to Rule 16b-3 [view details]
National Health Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as National . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About National Health Buy or Sell Advice
When is the right time to buy or sell National Health Investors? Buying financial instruments such as National Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having National Health in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Cars Thematic Idea Now
Cars
Domestic and international companies involved in manufacturing and serving automobiles and trucks. The Cars theme has 46 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Cars Theme or any other thematic opportunities.
| View All Next | Launch |
Check out National Health Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of National Health. If investors know National will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about National Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.14) | Dividend Share 3.6 | Earnings Share 3.13 | Revenue Per Share | Quarterly Revenue Growth (0.12) |
The market value of National Health Investors is measured differently than its book value, which is the value of National that is recorded on the company's balance sheet. Investors also form their own opinion of National Health's value that differs from its market value or its book value, called intrinsic value, which is National Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because National Health's market value can be influenced by many factors that don't directly affect National Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between National Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if National Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, National Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.